`To:
`Cc:
`
`Subject:
`Date:
`
`McLennan, Mark C.
`Trials
`*David.Cavanaugh@wilmerhale.com; Pirozzolo, Lisa; Shmidt, Vera; Prussia, Kevin S;
`*Robert.gunther@wilmerhale.com; Danford, Andrew J; abrausa@durietangri.com; *DDurie@durietangri.com;
`Hollis, Amanda; Lasky, Benjamin; #Pfizer_Genentech_IPRs; ddrivas@whitecase.com;
`sweingaertner@whitecase.com; athakore@whitecase.com; eric.majchrzak@whitecase.com; Hardman, Cynthia;
`Blais, Elaine Herrmann; Cerwinski, Robert V.; McLean, Sharlene; Fischer, Sarah; Fink, Sarah; Holland, Elizabeth J.
`IPR2017-00731, -00737, -01121, -01122: Exhibits 2146 and 2147
`Wednesday, May 16, 2018 2:18:10 PM
`
`Dear Honorable Board,
`
`Patent Owner filed new exhibits with its Motions for Observations on Cross-Examination (Exs. 2146
`and 2147 with Paper 88 in IPR2017-00731; Paper 90 in IPR2017-00737; and Ex. 2146 with Paper 76
`in IPR2017-01121; Paper 74 in IPR2017-01122). Petitioners in the above-captioned proceedings
`intend to object to these exhibits and seek their exclusion from the record.
`
`As Petitioners’ objections will be due after the oral hearing scheduled for Friday, May 18, Petitioners
`respectfully request the Board’s guidance on the appropriate way for Petitioners to preserve their
`objections and seek exclusion of the exhibits.
`
`Patent Owner has been informed of Petitioners’ request and did not oppose this email to the Board
`seeking clarification.
`
`Regards,
`Mark
`
`Mark C. McLennan
`-----------------------------------------------------
`KIRKLAND & ELLIS LLP
`601 Lexington Avenue, New York, NY 10022
`T +1 212 909 3451
`F +1 212 446 4900
`-----------------------------------------------------
`mark.mclennan@kirkland.com
`
`The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside
`information, and is intended only for the use of the addressee. It is the property of Kirkland & Ellis LLP or Kirkland & Ellis
`International LLP. Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and
`may be unlawful. If you have received this communication in error, please notify us immediately by return email or by email
`to postmaster@kirkland.com, and destroy this communication and all copies thereof, including all attachments.
`
`IPR2017-00731
`IPR2017-00737
`IPR2017-01121
`IPR2017-01122
`Ex. 3002
`
`